Home' Australian Pharmacist : Australian Pharmacist July 2013 Contents 42 Australian Pharmacist July 2013 I ©Pharmaceutical Society of Australia Ltd.
Chronic wound care gaining
The campaign for government subsidised
wound care moved a step closer in the
2013 Federal Budget.
Hot on the heels of its national petition
for subsidised wound care being tabled in
the Senate on Budget day, the Australian
Wound Management Association (AWMA)
welcomed the budget decision to provide
$0.3M to fund a study on improving chronic
wound management for Senior Australians.
AWMA -- whose membership comprises
mostly of nurses and other health
professionals -- saw its 1,160-signature
petition tabled by Senator Dean Smith
(Liberal, WA), a member of the Senate
Standing Committee on Community Affairs.
The petition noted that with prompt
best-practice care most wounds, including
difficult venous leg ulcers (VLU), can
be healed within 12 weeks. It sought
Senate support for full subsidisation of
best-practice wound management, a case
that AWMA had been advocating for
AWMA national president Dr Bill McGuiness
said: 'Without the early use of dressings
and specifically compression bandages
and stockings, healing is delayed, causing
avoidable pain and suffering and creating
unnecessary pressure on public hospitals
and other services.'
Dr McGuiness, Head of La Trobe University's
School of Nursing & Midwifery, said:
'At present, the barrier to wider use of
compression items for VLUs is their high
cost, which most Australian patients must
pay for personally. Many of these patients
are elderly pensioners who either make
sacrifices to afford the consumables,
or simply miss out on best-practice care.'
AWMA estimates that as many as
300,000 Australians currently experience
chronic wounds requiring management,
with around 42,600 people aged over
60 years having at least one VLU at any time.
A recent KPMG report, An Economic
Evaluation of Compression Therapy for
Venous Leg Ulcers, said wider access
to appropriate compression therapy
could deliver substantial savings to both
government and individual patients. The is
available from: www.awma.com.au
The $0.3M budget funding is earmarked for
a scoping study and cost benefit analysis
of options to better address chronic
wound management for Senior Australians
and is part of the Supporting Senior
'AWMA is delighted that the Government
has recognised the need to further
improve chronic wound management
for Seniors. AWMA sees this as a positive
stepping stone on the path to ensuring
best-practice management for every
Australian experiencing a chronic
wound. We look forward to assisting the
coordinators of the study in any way they
feel could be useful,' Dr McGuiness, said.
Senator Dean Smith and AWMA committee representative, Ann Marie Dunk.
Diabetes MedsCheck research
A six-month pilot implementation
program exploring better health
outcomes for people with
diabetes has started at 14 NSW
The program is a joint initiative between
Roche Diabetes Care and the University of
Technology Sydney (UTS).
The program aims to evaluate the
implementation of the Australian
Government's Diabetes MedsCheck
service and will investigate the impact of
Diabetes MedsCheck on health outcomes
for people with diabetes. It aims to
produce a sustainable MedsCheck model
that ensures evidence-based best practice
and the provision of quality services to
patients and pharmacies.
The program is being led by UTS
Professor Charlie Benrimoj, Head,
Graduate School of Health & Professor
of Pharmacy Practice, and will develop,
implement and evaluate the Diabetes
MedsCheck program in selected
participating community pharmacies
across NSW, Victoria and Queensland.
The 14 pharmacies in NSW will be joined
by a further 15.
The pilot will incorporate existing
professional services tools from Roche
Diagnostics, designed to aid pharmacy
employees to assist patients to improve
the management of their diabetes.
It will measure uptake of the Diabetes
MedsCheck service and the psychosocial
impact on people with diabetes, ensuring
that reiterations of the program improve
the quality of life and self-empowerment
of people living with diabetes and help
to alleviate diabetes-related depression.
From a pharmacy perspective,
the program will assess the benefits of
implementing professional services to
Links Archive Australian Pharmacist June 2013 Australian Pharmacist August 2013 Navigation Previous Page Next Page